Overall world revenue for Biological Safety Testing Market, 2024 to 2034 in terms of value the market will surpass US$3,900 million in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
The Biological Safety Testing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Of particular concern is the vulnerability of personal health information (PHI), which, if compromised, can fuel a myriad of nefarious activities including financial and medical fraud, identity theft, and intelligence gathering for malicious purposes. Compounding this threat is the clandestine nature of breaches involving PHI, often evading detection for extended periods, thus amplifying the potential impact on individuals and organizations alike.
Moreover, the advent of sophisticated AI-driven systems introduces novel risks, as attackers may exploit vulnerabilities to undermine the integrity of underlying AI models through data poisoning attacks. Additionally, the theft of intellectual property via model stealing techniques poses a formidable challenge, further exacerbating concerns surrounding data security and privacy in the biological safety testing market.
Against a backdrop of heightened cybersecurity threats and intensified regulatory scrutiny, companies operating in the biological safety testing market face formidable challenges in safeguarding sensitive data generated throughout testing processes. The imperative of ensuring data security and privacy not only demands robust technological safeguards but also necessitates comprehensive risk management strategies and proactive compliance initiatives to mitigate potential vulnerabilities and safeguard the integrity of critical data assets. Failure to address these challenges adequately may impede market growth and erode stakeholder trust, underscoring the urgency for concerted efforts to fortify data security and privacy measures within the biological safety testing industry.
The Biological Safety Testing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Heightened Data Security and Privacy Concerns Hampering Market Growth
The exponential growth in data volume within the biopharmaceutical sector has intensified the imperative of ensuring data security and privacy, presenting a significant restraint in the biological safety testing market. As biopharmaceutical businesses amass vast quantities of information encompassing patient data, research findings, and regulatory compliance records, they become increasingly susceptible to malicious activities perpetrated by both criminal entities and state-sponsored actors.Of particular concern is the vulnerability of personal health information (PHI), which, if compromised, can fuel a myriad of nefarious activities including financial and medical fraud, identity theft, and intelligence gathering for malicious purposes. Compounding this threat is the clandestine nature of breaches involving PHI, often evading detection for extended periods, thus amplifying the potential impact on individuals and organizations alike.
Moreover, the advent of sophisticated AI-driven systems introduces novel risks, as attackers may exploit vulnerabilities to undermine the integrity of underlying AI models through data poisoning attacks. Additionally, the theft of intellectual property via model stealing techniques poses a formidable challenge, further exacerbating concerns surrounding data security and privacy in the biological safety testing market.
Against a backdrop of heightened cybersecurity threats and intensified regulatory scrutiny, companies operating in the biological safety testing market face formidable challenges in safeguarding sensitive data generated throughout testing processes. The imperative of ensuring data security and privacy not only demands robust technological safeguards but also necessitates comprehensive risk management strategies and proactive compliance initiatives to mitigate potential vulnerabilities and safeguard the integrity of critical data assets. Failure to address these challenges adequately may impede market growth and erode stakeholder trust, underscoring the urgency for concerted efforts to fortify data security and privacy measures within the biological safety testing industry.
Key Questions Answered
- How is the biological safety testing market evolving?
- What is driving and restraining the biological safety testing market?
- How will each biological safety testing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each biological safety testing submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading biological safety testing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the biological safety testing projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of biological safety testing projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Biological Safety Testing market?
- Where is the biological safety testing market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Biological Safety Testing market today, and over the next 10 years:
- This 299-page report provides 99 tables and 177 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Product
- Consumables
- Instruments
- Services & Others
Application Outlook
- Cellular & Gene Therapy
- Monoclonal Antibodies (mAbs)
- Vaccines & Therapeutics
- Blood-based Therapy & Others
Tests Outlook
- Endotoxin Tests
- Mycoplasma Tests
- Sterility Tests
- Residual Host Contamination Detection Tests
- Bioburden Tests
- Virus Safety Tests
- Others
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Leading companies profiled in the report
- Almac Group
- Charles River Laboratories
- Clean Cells
- Creative Biogene
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Laboratory Corporation of America
- Lonza Group
- Merck KGaA
- Sartorius AG
- SGS Société Générale de Surveillance SA
- Thermo Fisher Scientific Inc.
- Wuxi Apptec
How will the Biological Safety Testing Market, 2024 to 2034 report help you?
In summary, the 290+ page report provides you with the following knowledge:- Revenue forecasts to 2034 for Biological Safety Testing Market, 2024 to 2034 Market, with forecasts for product, application, and tests, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Biological Safety Testing Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Biological Safety Testing Market, 2024 to 2034.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Biological Safety Testing Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.Table of Contents
1 Report Overview1.1 Objectives of the Study
1.2 Introduction to Biological Safety Testing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Biologics Boom is Fuelling the Demand for Safety Testing
3.3.1.2 Increasing Pharma Investments to Boost the Biologics Safety Testing Market Demand
3.3.1.3 Biotech Investment Surge Propels Global Biological Safety Testing Market
3.3.1.4 Multinational Leaders Drive Biologics Safety Testing Market Expansion through Strategic Investments and Collaborations
3.3.2 Market Restraining Factors
3.3.2.1 Navigating Challenges in Biologic Safety Testing - A Complex Landscape
3.3.2.2 Heightened Data Security and Privacy Concerns
3.3.3 Market Opportunities
3.3.3.1 Digital Tech and AI to Transform the Biological Safety Testing Market
3.3.3.2 Increasing Demand for Generics and Biosimilars to act as Catalyst for the market Growth
3.4 Supply Chain Analysis
3.5 Regulatory Framework
3.6 Emerging Markets and Megatrends
3.7 Porter’s Five Forces Analysis
3.7.1 Bargaining Power of Suppliers
3.7.2 Bargaining Power of Buyers
3.7.3 Competitive Rivalry
3.7.4 Threat of Substitutes
3.7.5 Threat of New Entrants
3.8 PEST Analysis
4 Biological Safety Testing Market Analysis by Products
4.1 Key Findings
4.2 Products Segment: Market Attractiveness Index
4.3 Biological Safety Testing Market Size Estimation and Forecast by Products
4.4 Consumables
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Instruments
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Service & Others
4.6.1 Market Size by Region, 2024-2034 (US$ Million)
4.6.2 Market Share by Region, 2024 & 2034 (%)
5 Biological Safety Testing Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Biological Safety Testing Market Size Estimation and Forecast by Application
5.4 Cellular & Gene Therapy
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Monoclonal Antibodies (mAbs)
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Vaccines & Therapeutics
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Blood-based Therapy & Others
5.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.7.2 Market Share by Region, 2024 & 2034 (%)
6 Biological Safety Testing Market Analysis by Test
6.1 Key Findings
6.2 Test Segment: Market Attractiveness Index
6.3 Biological Safety Testing Market Size Estimation and Forecast by Test
6.4 Endotoxin Tests
6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Mycoplasma Tests
6.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Sterility Tests
6.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Residual Host Contamination Detection Tests
6.7.1 Market Size by Region, 2024-2034 (US$ Million)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Bioburden Tests
6.8.1 Market Size by Region, 2024-2034 (US$ Million)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Virus Safety Tests
6.9.1 Market Size by Region, 2024-2034 (US$ Million)
6.9.2 Market Share by Region, 2024 & 2034 (%)
6.10 Others
6.10.1 Market Size by Region, 2024-2034 (US$ Million)
6.10.2 Market Share by Region, 2024 & 2034 (%)
7 Biological Safety Testing Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Biological Safety Testing Market Analysis
8.1 Key Findings
8.2 North America Biological Safety Testing Market Attractiveness Index
8.3 North America Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
8.4 North America Biological Safety Testing Market Size Estimation and Forecast by Country
8.5 North America Biological Safety Testing Market Size Estimation and Forecast by Products
8.6 North America Biological Safety Testing Market Size Estimation and Forecast by Application
8.7 North America Biological Safety Testing Market Size Estimation and Forecast by Tests
8.8 U.S. Biological Safety Testing Market Analysis
8.9 Canada Biological Safety Testing Market Analysis
9 Europe Biological Safety Testing Market Analysis
9.1 Key Findings
9.2 Europe Biological Safety Testing Market Attractiveness Index
9.3 Europe Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
9.4 Europe Biological Safety Testing Market Size Estimation and Forecast by Country
9.5 Europe Biological Safety Testing Market Size Estimation and Forecast by Product
9.6 Europe Biological Safety Testing Market Size Estimation and Forecast by Application
9.7 Europe Biological Safety Testing Market Size Estimation and Forecast by Tests
9.8 Germany Biological Safety Testing Market Analysis
9.9 France Biological Safety Testing Market Analysis
9.10 UK Biological Safety Testing Market Analysis
9.11 Italy Biological Safety Testing Market Analysis
9.12 Spain Biological Safety Testing Market Analysis
9.13 Rest of Europe Biological Safety Testing Market Analysis
10 Asia Pacific Biological Safety Testing Market Analysis
10.1 Key Findings
10.2 Asia Pacific Biological Safety Testing Market Attractiveness Index
10.3 Asia Pacific Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
10.4 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Country
10.5 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Product
10.6 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Application
10.7 Asia Pacific Biological Safety Testing Market Size Estimation and Forecast by Tests
10.8 Japan Biological Safety Testing Market Analysis
10.9 China Biological Safety Testing Market Analysis
10.10 India Biological Safety Testing Market Analysis
10.11 Australia Biological Safety Testing Market Analysis
10.12 South Korea Biological Safety Testing Market Analysis
10.13 Rest of Asia Pacific Biological Safety Testing Market Analysis
11 Latin America Biological Safety Testing Market Analysis
11.1 Key Findings
11.2 Latin America Biological Safety Testing Market Attractiveness Index
11.3 Latin America Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 Latin America Biological Safety Testing Market Size Estimation and Forecast by Country
11.5 Latin America Biological Safety Testing Market Size Estimation and Forecast by Product
11.6 Latin America Biological Safety Testing Market Size Estimation and Forecast by Application
11.7 Latin America Biological Safety Testing Market Size Estimation and Forecast by Tests
11.8 Brazil Biological Safety Testing Market Analysis
11.9 Mexico Biological Safety Testing Market Analysis
11.10 Rest of Latin America Biological Safety Testing Market Analysis
12 MEA Biological Safety Testing Market Analysis
12.1 Key Findings
12.2 MEA Biological Safety Testing Market Attractiveness Index
12.3 MEA Biological Safety Testing Market by Country, 2024, 2029 & 2034 (US$ Million)
12.4 MEA Biological Safety Testing Market Size Estimation and Forecast by Country
12.5 MEA Biological Safety Testing Market Size Estimation and Forecast by Product
12.6 MEA Biological Safety Testing Market Size Estimation and Forecast by Application
12.7 MEA Biological Safety Testing Market Size Estimation and Forecast by Tests
12.8 GCC Biological Safety Testing Market Analysis
12.9 South Africa Biological Safety Testing Market Analysis
12.10 Rest of MEA Biological Safety Testing Market Analysis
13 Next Generation Sequencing in Biological Safety Testing Market Analysis
13.1 Market Overview
13.2 Market Dynamics Key Findings
13.3 Market Dynamics
13.4 Impact Analysis
13.4.1 Market Driving Factors
13.4.1.1 Cost-effective Rise of Next-Generation Sequencing is Revolutionizing Biological Safety Testing
13.4.1.2 Elevating Biological Safety Testing with Superior Sensitivity and Resolution
13.4.2 Market Restraining Factors
13.4.2.1 Integration, Scalability, and Data Interpretation
13.4.2.2 Key Challenges in Expanding NGS Test Menus for Biological Safety Testing
13.4.3 Market Opportunities
13.4.3.1 Long-read Sequencing to Create Incremental Market Opportunity
13.5 Product Segment: Market Attractiveness Index
13.5.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Product
13.5.1.1 Consumables
13.5.1.2 Instruments
13.5.1.3 Services & Others
13.6 Sequencing Segment: Market Attractiveness Index
13.6.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Sequencing
13.6.1.1 Short-read Sequencing
13.6.1.2 Long-read Sequencing
13.7 Test Segment: Market Attractiveness Index
13.7.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Test
13.7.1.1 Sterility Tests
13.7.1.2 Mycoplasma Tests
13.7.1.3 Adventitious Virus Detection Tests
13.7.1.4 Sequence Identity Confirmation
13.7.1.5 Others
13.8 Regional Segment: Market Attractiveness Index
13.8.1 Next Generation Sequencing in Biological Safety Testing Market Size Estimation and Forecast by Region
13.8.1.1 North America
13.8.1.2 Europe
13.8.1.3 Asia Pacific
13.8.1.4 Latin America
13.8.1.5 MEA
14 Company Profiles
14.1 Competitive Landscape, 2023
14.2 Strategic Outlook
14.3 Charles River Laboratories
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2019-2023
14.3.3.2 Business Segment Market Shares, 2023
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.3.6 SWOT Analysis
14.4 Thermo Fisher Scientific Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2019-2023
14.4.3.2 R&D, 2019-2023
14.4.3.3 Regional Market Shares, 2023
14.4.3.4 Business Segment Market Shares, 2023
14.4.4 Service Benchmarking
14.4.5 Strategic Outlook
14.4.6 SWOT Analysis
14.5 Merck KGaA
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2019-2023
14.5.3.2 R&D, 2019-2023
14.5.3.3 Regional Market Shares, 2023
14.5.3.4 Business Segment Market Shares, 2023
14.5.4 Service Benchmarking
14.5.5 Strategic Outlook
14.5.6 SWOT Analysis
14.6 F. Hoffmann-La Roche Ltd.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2019-2023
14.6.3.2 R&D, 2019-2023
14.6.3.3 Regional Market Shares, 2023
14.6.3.4 Business Segment Market Shares, 2023
14.6.4 Service Benchmarking
14.7 Lonza Group
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2019-2023
14.7.3.2 R&D, 2019-2023
14.7.3.3 Regional Market Shares, 2023
14.7.3.4 Business Segment Market Shares, 2023
14.7.4 Service Benchmarking
14.7.5 Strategic Outlook
14.8 Laboratory Corporation of America
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2019-2023
14.8.3.2 Regional Market Shares, 2023
14.8.3.3 Business Segment Market Shares, 2023
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 Eurofins Scientific
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2019-2023
14.9.3.2 Regional Market Shares, 2023
14.9.4 Service Benchmarking
14.9.5 Strategic Outlook
14.10 SGS Société Générale de Surveillance SA
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2019-2023
14.10.3.2 Regional Market Shares, 2023
14.10.4 Service Benchmarking
14.10.5 Strategic Outlook
14.11 Sartorius AG
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2019-2023
14.11.3.2 R&D, 2019-2023
14.11.3.3 Regional Market Shares, 2023
14.11.3.4 Business Segment Market Shares, 2023
14.11.4 Service Benchmarking
14.12 WuXi AppTec
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2019-2023
14.12.3.2 R&D, 2019-2023
14.12.3.3 Regional Market Shares, 2023
14.12.3.4 Business Segment Market Shares, 2023
14.12.4 Service Benchmarking
14.13 Almac Group
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Service Benchmarking
14.13.4 Strategic Outlook
14.14 Clean Cells
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Service Benchmarking
14.14.4 Strategic Outlook
14.15 Creative Biogene
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Service Benchmarking
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Biological Safety Testing Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 3 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 4 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 5 Service & Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 6 Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 7 Cellular & Gene Therapy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 8 Monoclonal Antibodies (mAbs) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 9 Vaccines & Therapeutics Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 10 Blood-based Therapy & Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 11 Biological Safety Testing Market Forecast by Test, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 12 Endotoxin Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 13 Mycoplasma Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 14 Sterility Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 15 Residual Host Contamination Detection Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 16 Bioburden Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 17 Virus Safety Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 18 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 19 Biological Safety Testing Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 20 North America Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 21 North America Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 22 North America Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 23 North America Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 24 U.S. Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 25 Canada Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 26 Europe Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 27 Europe Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 28 Europe Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 29 Europe Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 30 Germany Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 31 France Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 32 UK Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 33 Italy Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 34 Spain Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 35 Rest of Europe Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 36 Asia Pacific Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 37 Asia Pacific Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 38 Asia Pacific Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 39 Asia Pacific Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 40 Japan Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 41 China Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 42 India Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 43 Australia Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 44 South Korea Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 45 Rest of Asia Pacific Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 46 Latin America Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 47 Latin America Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 48 Latin America Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 49 Latin America Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 50 Brazil Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 51 Mexico Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 52 Rest of Latin America Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 53 MEA Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 54 MEA Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 55 MEA Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 56 MEA Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 57 GCC Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 58 South Africa Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 59 Rest of MEA Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 60 Next Generation Sequencing in Biological Safety Testing Market Forecast by Product, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 61 Next Generation Sequencing in Biological Safety Testing Market Forecast by Sequencing, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 62 Next Generation Sequencing in Biological Safety Testing Market Forecast by Test, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 63 Next Generation Sequencing in Biological Safety Testing Market Forecast by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Table 64 Strategic Outlook
Table 65 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 Charles River Laboratories: Service Benchmarking
Table 67 Charles River Laboratories: Strategic Outlook
Table 68 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 70 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 71 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Merck KGaA: Service Benchmarking
Table 73 Merck KGaA: Strategic Outlook
Table 74 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 F. Hoffmann-La Roche Ltd.: Service Benchmarking
Table 76 Lonza Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Lonza Group: Service Benchmarking
Table 78 Lonza Group: Strategic Outlook
Table 79 Laboratory Corporation of America: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Laboratory Corporation of America: Service Benchmarking
Table 81 Laboratory Corporation of America: Strategic Outlook
Table 82 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Eurofins Scientific: Service Benchmarking
Table 84 Eurofins Scientific: Strategic Outlook
Table 85 SGS Société Générale de Surveillance SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 SGS Société Générale de Surveillance SA: Service Benchmarking
Table 87 SGS Société Générale de Surveillance SA: Strategic Outlook
Table 88 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Sartorius AG: Service Benchmarking
Table 90 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 WuXi AppTec: Service Benchmarking
Table 92 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Almac Group: Service Benchmarking
Table 94 Almac Group: Strategic Outlook
Table 95 Clean Cells: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Clean Cells: Service Benchmarking
Table 97 Clean Cells: Strategic Outlook
Table 98 Creative Biogene: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Creative Biogene: Service Benchmarking
List of Figures
Figure 1 Biological Safety Testing Market Segmentation
Figure 2 Biological Safety Testing Market by Products: Market Attractiveness Index
Figure 3 Biological Safety Testing Market by Application: Market Attractiveness Index
Figure 4 Biological Safety Testing Market by Tests: Market Attractiveness Index
Figure 5 Biological Safety Testing Market Attractiveness Index by Region
Figure 6 Biological Safety Testing Market: Market Dynamics
Figure 7 Biological Safety Testing Market: Impact Analysis
Figure 8 Globally Granted Patents for Biologics, 2019 - 2023
Figure 9 Pharma R&D Investment (US$ Billion)
Figure 10 Biotechnology Investment by VC/PE
Figure 11 Biotechnology Investment by VC/PE, by Region
Figure 12 Europe Pharmaceutical and Generics & Biosimilar Market (US$ Billion)
Figure 13 Biological Safety Testing Industry: Supply Chain Analysis
Figure 14 Biological Safety Testing Market: Porter’s Five Forces Analysis
Figure 15 Biological Safety Testing Market: PEST Analysis
Figure 16 Biological Safety Testing Market by Products: Market Attractiveness Index
Figure 17 Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %)
Figure 18 Biological Safety Testing Market Share Forecast by Products, 2024, 2029, 2034 (%)
Figure 19 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 20 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 22 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Service & Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 24 Service & Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Biological Safety Testing Market by Application: Market Attractiveness Index
Figure 26 Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 27 Biological Safety Testing Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 28 Cellular & Gene Therapy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 29 Cellular & Gene Therapy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Monoclonal Antibodies (mAbs) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 31 Monoclonal Antibodies (mAbs) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 Vaccines & Therapeutics Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 33 Vaccines & Therapeutics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Blood-based Therapy & Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 35 Blood-based Therapy & Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Biological Safety Testing Market by Test: Market Attractiveness Index
Figure 37 Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 38 Biological Safety Testing Market Share Forecast by Tests, 2024, 2029, 2034 (%)
Figure 39 Endotoxin Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 40 Endotoxin Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Mycoplasma Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 42 Mycoplasma Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Sterility Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 44 Sterility Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Residual Host Contamination Detection Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 46 Residual Host Contamination Detection Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Bioburden Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 48 Bioburden Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Virus Safety Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 50 Virus Safety Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 52 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Biological Safety Testing Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 54 Biological Safety Testing Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 55 Biological Safety Testing Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 56 North America Biological Safety Testing Market Attractiveness Index
Figure 57 North America Biological Safety Testing Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 58 North America Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 59 North America Biological Safety Testing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 60 North America Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %)
Figure 61 North America Biological Safety Testing Market Share Forecast by Products, 2024 & 2034 (%)
Figure 62 North America Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 63 North America Biological Safety Testing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 64 North America Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 65 North America Biological Safety Testing Market Share Forecast by Tests, 2024 & 2034 (%)
Figure 66 U.S. Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 67 Canada Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 68 Europe Biological Safety Testing Market Attractiveness Index
Figure 69 Europe Biological Safety Testing Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 70 Europe Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 71 Europe Biological Safety Testing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 72 Europe Biological Safety Testing Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 73 Europe Biological Safety Testing Market Share Forecast by Product, 2024 & 2034 (%)
Figure 74 Europe Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 75 Europe Biological Safety Testing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 76 Europe Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 77 Europe Biological Safety Testing Market Share Forecast by Tests, 2024 & 2034 (%)
Figure 78 Germany Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 79 France Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 80 UK Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 81 Italy Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 82 Spain Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 83 Rest of Europe biological safety testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 84 Asia Pacific Biological Safety Testing Market Attractiveness Index
Figure 85 Asia Pacific Biological Safety Testing Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 86 Asia Pacific Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 87 Asia Pacific Biological Safety Testing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 88 Asia Pacific Biological Safety Testing Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 89 Asia Pacific Biological Safety Testing Market Share Forecast by Product, 2024 & 2034 (%)
Figure 90 Asia Pacific Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 91 Asia Pacific Biological Safety Testing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 92 Asia Pacific Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 93 Asia Pacific Biological Safety Testing Market Share Forecast by Tests, 2024 & 2034 (%)
Figure 94 Japan Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 95 China Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 96 India Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 97 Australia Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 98 South Korea Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 99 Rest of Asia Pacific Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 100 Latin America Biological Safety Testing Market Attractiveness Index
Figure 101 Latin America Biological Safety Testing Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 102 Latin America Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 103 Latin America Biological Safety Testing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 104 Latin America Biological Safety Testing Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 105 Latin America Biological Safety Testing Market Share Forecast by Product, 2024 & 2034 (%)
Figure 106 Latin America Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 107 Latin America Biological Safety Testing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 108 Latin America Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 109 Latin America Biological Safety Testing Market Share Forecast by Tests, 2024 & 2034 (%)
Figure 110 Brazil Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 111 Mexico Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 112 Rest of Latin America Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 113 MEA Biological Safety Testing Market Attractiveness Index
Figure 114 MEA Biological Safety Testing Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 115 MEA Biological Safety Testing Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 116 MEA Biological Safety Testing Market Share Forecast by Country, 2024 & 2034 (%)
Figure 117 MEA Biological Safety Testing Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 118 MEA Biological Safety Testing Market Share Forecast by Product, 2024 & 2034 (%)
Figure 119 MEA Biological Safety Testing Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 120 MEA Biological Safety Testing Market Share Forecast by Application, 2024 & 2034 (%)
Figure 121 MEA Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 122 MEA Biological Safety Testing Market Share Forecast by Tests, 2024 & 2034 (%)
Figure 123 GCC Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 124 South Africa Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 125 Rest of MEA Biological Safety Testing Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 126 Next Generation Sequencing in Biological Safety Testing Market: Market Dynamics
Figure 127 Next Generation Sequencing in Biological Safety Testing Market: Impact Analysis
Figure 128 Cost per Whole Genome Sequencing (US$), 2011 - 2022
Figure 129 Next Generation Sequencing in Biological Safety Testing Market by Product: Market Attractiveness Index
Figure 130 Next Generation Sequencing in Biological Safety Testing Market Forecast by Products, 2024-2034 (US$ Million, AGR %)
Figure 131 Next Generation Sequencing in Biological Safety Testing Market Share Forecast by Products, 2024, 2029, 2034 (%)
Figure 132 Next Generation Sequencing in Biological Safety Testing Market by Sequencing: Market Attractiveness Index
Figure 133 Next Generation Sequencing in Biological Safety Testing Market Forecast by Sequencing, 2024-2034 (US$ Million, AGR %)
Figure 134 Next Generation Sequencing in Biological Safety Testing Market Share Forecast by Sequencing, 2024, 2029, 2034 (%)
Figure 135 Next Generation Sequencing in Biological Safety Testing Market by Tests: Market Attractiveness Index
Figure 136 Next Generation Sequencing in Biological Safety Testing Market Forecast by Tests, 2024-2034 (US$ Million, AGR %)
Figure 137 Next Generation Sequencing in Biological Safety Testing Market Share Forecast by Tests, 2024, 2029, 2034 (%)
Figure 138 Next Generation Sequencing in Biological Safety Testing Market by Region: Market Attractiveness Index
Figure 139 Next Generation Sequencing in Biological Safety Testing Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 140 Next Generation Sequencing in Biological Safety Testing Market Share Forecast by Region, 2024, 2029, 2034 (%)
Figure 141 Biological Safety Testing Market: Company Share/Ranking, 2023
Figure 142 Charles River Laboratories: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 143 Charles River Laboratories: Business Segment Market Shares, 2023
Figure 144 Charles River Laboratories: SWOT Analysis
Figure 145 Thermo Fisher Scientific Inc.: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 146 Thermo Fisher Scientific Inc.: R&D, 2019-2023 (US$ Billion, AGR %)
Figure 147 Thermo Fisher Scientific Inc.: Regional Market Shares, 2023
Figure 148 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2023
Figure 149 Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 150 Merck KGaA: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 151 Merck KGaA: R&D, 2019-2023 (US$ Billion, AGR %)
Figure 152 Merck KGaA: Regional Market Shares, 2023
Figure 153 Merck KGaA: Business Segment Market Shares, 2023
Figure 154 Merck KGaA: SWOT Analysis
Figure 155 F. Hoffmann-La Roche Ltd.: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 156 F. Hoffmann-La Roche Ltd.: R&D, 2019-2023 (US$ Billion, AGR %)
Figure 157 F. Hoffmann-La Roche Ltd.: Regional Market Shares, 2023
Figure 158 F. Hoffmann-La Roche Ltd.: Business Segment Market Shares, 2023
Figure 159 Lonza Group: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 160 Lonza Group: R&D, 2019-2023 (US$ Million, AGR%)
Figure 161 Lonza Group: Regional Market Shares, 2023
Figure 162 Lonza Group: Business Segment Market Shares, 2023
Figure 163 Laboratory Corporation of America: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 164 Laboratory Corporation of America: Regional Market Shares, 2023
Figure 165 Laboratory Corporation of America: Business Segment Market Shares, 2023
Figure 166 Eurofins Scientific: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 167 Eurofins Scientific: Regional Market Shares, 2023
Figure 168 SGS Société Générale de Surveillance SA: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 169 SGS Société Générale de Surveillance SA: Regional Market Shares, 2023
Figure 170 Sartorius AG: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 171 Sartorius AG: R&D, 2019-2023 (US$ Billion, AGR %)
Figure 172 Sartorius AG: Regional Market Shares, 2023
Figure 173 Sartorius AG: Business Segment Market Shares, 2023
Figure 174 WuXi AppTec: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 175 WuXi AppTec: R&D, 2019-2023 (US$ Million, AGR%)
Figure 176 WuXi AppTec: Regional Market Shares, 2023
Figure 177 WuXi AppTec: Business Segment Market Shares, 2023
Companies Mentioned
- Almac Group
- Charles River Laboratories
- Clean Cells
- Creative Biogene
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Laboratory Corporation of America
- Lonza Group
- Merck KGaA
- Sartorius AG
- SGS Société Générale de Surveillance SA
- Thermo Fisher Scientific Inc.
- Wuxi Apptec
- Bio-Rad Laboratories
- Dompé Farmaceutici
- Euformatics
- Genetrics
- Grifols
- HealthVerity, Inc.
- Illumina Inc.
- JADE Biomedical
- Macrogen
- Menarini Group
- MGI Tech Co. Ltd. (MGI)
- Novogene Europe
- Olink Holding AB
- Pall Corporation
- PathoQuest SAS
- Pensabio
- Pharmamar
- RightSource
- Samsung Biologics
- Synplogen
- Brazilian Health Regulatory Agency (ANVISA)
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- European Medicines Agency (EMA)
- Food and Drug Administration (FDA)
- Good Laboratory Practice (GLP)
- Good Manufacturing Practice (GMP)
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
- Italian Medicines Agency (AIFA)
- National Institute of Health (ISS)
- National Institutes of Pharmaceutical Education & Research (NIPERs)
- National Research and Innovation Agency (BRIN)
- Pharmaceuticals and Medical Devices Agency (PMDA)
- Public Health Agency of Canada (PHAC
- Spanish Agency of Medicines and Medical Devices (AEMPS)
- U.S. Biomedical Advanced Research and Development Authority (BARDA)
- United States Pharmacopeia (USP)
